Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01565317 · ClinicalTrials.gov registry record · NA
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01565317 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 50 participants.
The verdict
NCT01565317, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the impact of improving diabetes control through weight reduction and lifestyle changes on a common diabetes complication called peripheral neuropathy.
Interventions
- OTHER Weight Achievement and Intensive Treatment (Why WAIT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01565317
The ClinicalTrials.gov registry entry for NCT01565317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Weight Achievement and Intensive Treatment (Why WAIT) is the first listed.
NCT01565317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01565317 about?
NCT01565317 is a clinical study titled "Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy". The purpose of this study is to find out the impact of improving diabetes control through weight reduction and lifestyle changes on a common diabetes complication called peripheral neuropathy.
What is the current status of trial NCT01565317?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01565317?
The interventions under investigation include: Weight Achievement and Intensive Treatment (Why WAIT) (OTHER).
Who is sponsoring clinical trial NCT01565317?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.